![Izhak Haviv](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Izhak Haviv is the founder and current Chief Scientific Officer of AID Genomics Group Ltd., which is founded in 2018.
Posizioni attive di Izhak Haviv
Società | Posizione | Inizio |
---|---|---|
AID Genomics Group Ltd.
![]() AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Fondatore | 01/01/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
AID Genomics Group Ltd.
![]() AID Genomics Group Ltd. Pharmaceuticals: MajorHealth Technology AID Genomics Group Ltd. is a research and development driven Israeli company that focuses on precision medicine-based diagnostics for oncology, hereditary rare diseases, and infectious diseases. AID Genomics Group is based in Rehovot, IL and was founded in 2018 by King Shiu Wu, Snir Zano, and Izhak Haviv. The company's advanced testing platforms were developed by a team of experts in oncology, molecular biology, molecular pathology, genomics, and bioinformatics. Snir Zano has been the CEO since 2018. | Health Technology |
- Borsa valori
- Insiders
- Izhak Haviv